
Zentalis Pharmaceuticals, Inc.
ZNTLHealthcare|Biotechnology|US
$1.72
+0.01 (+0.58%)
Tangible Book / Share
$2.04
Cash / Share
$2.49
Ownership Breakdown
68.2%
Float
71.2M
Shares Outstanding
48.6M
Float Shares
Major Holders (30)
Combined: 141.6%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Walters William T | Individual | 18.80% | 17,844,973 | Aug 19, 2026 | 13D/G |
| Walters Group | Partnership | 18.80% | 17,844,973 | Aug 19, 2026 | 13D/G |
| Walters, Susan B. | Individual | 18.80% | 17,844,973 | Aug 19, 2026 | 13D/G |
| Kush Parmar | Individual | 6.40% | 4,838,571 | Dec 30, 2025 | 13D/G |
| Andrew J. Schwab | Individual | 6.40% | 4,838,571 | Dec 30, 2025 | 13D/G |
| Finny Kuruvilla, M.D., Ph. D. | HC, IN | 6.28% | 4,475,054 | Feb 14, 2025 | 13D/G |
| 5AM Opportunities II, L.P. | Partnership | 5.20% | 3,947,913 | Dec 30, 2025 | 13D/G |
| 5AM Opportunities II (GP), LLC | Other | 5.20% | 3,947,913 | Dec 30, 2025 | 13D/G |
| Squadron Capital Management LLC | IA, HC | 5.10% | 3,676,900 | Mar 3, 2026 | 13D/G |
| William Blank | HC, IN | 5.10% | 3,676,900 | Mar 3, 2026 | 13D/G |
| Matthew Sesterhenn | HC, IN | 5.10% | 3,676,900 | Mar 3, 2026 | 13D/G |
| Squadron Master Fund LP | Partnership | 5.10% | 3,676,900 | Mar 3, 2026 | 13D/G |
| The Vanguard Group | Investment adviser | 4.59% | 3,271,240 | Jan 31, 2025 | 13D/G |
| BlackRock, Inc. | Holding company | 4.10% | 3,871,884 | Oct 27, 2026 | 13D/G |
| Kenneth Griffin | HC, IN | 3.90% | 2,737,221 | Nov 14, 2024 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 3.70% | 2,630,035 | Nov 14, 2024 | 13D/G |
| Citadel GP LLC | HC, OO | 3.70% | 2,630,035 | Nov 14, 2024 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 3.70% | 2,630,035 | Nov 14, 2024 | 13D/G |
| Barclays PLC | Holding company | 3.17% | 2,263,328 | Aug 13, 2026 | 13D/G |
| Israel A. Englander | Individual | 1.30% | 902,521 | Oct 14, 2025 | 13D/G |
| Millennium Management LLC | Other | 1.30% | 902,521 | Oct 14, 2025 | 13D/G |
| Millennium Group Management LLC | Other | 1.30% | 902,521 | Oct 14, 2025 | 13D/G |
| 5AM Opportunities Master Fund L.P. | Partnership | 1.20% | 890,658 | Dec 30, 2025 | 13D/G |
| 5AM Opportunities (GP), LLC | Other | 1.20% | 890,658 | Dec 30, 2025 | 13D/G |
| Anna Yaeger | Individual | 1.20% | 890,658 | Dec 30, 2025 | 13D/G |
| FMR LLC | Holding company | 0.20% | 175,863 | Dec 6, 2024 | 13D/G |
| Abigail P. Johnson | Individual | 0.20% | 175,863 | Dec 6, 2024 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.20% | 107,186 | Nov 14, 2024 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.20% | 107,186 | Nov 14, 2024 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.20% | 107,186 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 12,944,400 acquired · 7,555,372 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Bruns Ingmar | Chief Medical Officer | Sep 30, 2026 | AWARD | 9,727 | $2.18 | $21.2K | Form 4 |
| WALTERS GROUP | 10 percent owner | Aug 14, 2026 | BUY | 4,335,000 | $3.50 | $15.2M | Form 4 |
| Johnson David Michael | director | Jun 16, 2026 | AWARD | 57,100 | — | — | Form 4 |
| Skvarka Jan | director | Jun 16, 2026 | AWARD | 57,100 | — | — | Form 4 |
| Walker Luke Nathaniel | director | Jun 16, 2026 | AWARD | 57,100 | — | — | Form 4 |
| Kariuki Enoch | director | Jun 16, 2026 | AWARD | 57,100 | — | — | Form 4 |
| Myers Scott Dunseth | director | Jun 16, 2026 | AWARD | 57,100 | — | — | Form 4 |
| Campbell Shannon | director | May 26, 2026 | AWARD | 114,200 | — | — | Form 4 |
| Campbell Shannon | director: | May 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Feb 6, 2026 | SELL | 2,962 | $2.43 | $7.2K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Feb 9, 2026 | SELL | 335 | $2.39 | $801.62 | Form 4 |
| Vultaggio Vincent | PAO and PFO | Feb 6, 2026 | SELL | 29,951 | $2.43 | $72.8K | Form 4 |
| Vultaggio Vincent | PAO and PFO | Feb 9, 2026 | SELL | 3,379 | $2.39 | $8.1K | Form 4 |
| Vultaggio Vincent | PAO and PFO | Feb 10, 2026 | SELL | 6,894 | $2.42 | $16.7K | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Feb 6, 2026 | SELL | 7,866 | $2.43 | $19.1K | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Feb 9, 2026 | SELL | 889 | $2.39 | $2.1K | Form 4 |
| Vultaggio Vincent | PAO and PFO | Feb 2, 2026 | SELL | 2,540 | $2.55 | $6.5K | Form 4 |
| Vultaggio Vincent | PAO and PFO | Feb 3, 2026 | SELL | 556 | $2.52 | $1.4K | Form 4 |
| Vultaggio Vincent | PAO and PFO | Jan 8, 2026 | AWARD | 100,000 | $2.84 | $284.0K | Form 4 |
| Bucher James B | Chief Legal Officer | Jan 8, 2026 | AWARD | 100,000 | $2.84 | $284.0K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Jan 8, 2026 | AWARD | 365,000 | $2.84 | $1.0M | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Jan 8, 2026 | AWARD | 775,000 | $2.84 | $2.2M | Form 4 |
| WALTERS GROUP | 10 percent owner | Dec 31, 2025 | BUY | 6,459,973 | $1.20 | $7.8M | Form 4 |
| WALTERS GROUP | 10 percent owner | Dec 15, 2025 | OTHER | 0 | — | — | Form 4 |
| Matrix Capital Management Company, LP | 10 percent owner | Dec 15, 2025 | SELL | 7,500,000 | $1.33 | $10.0M | Form 4 |
| Bucher James B | Chief Legal Officer | Oct 1, 2025 | AWARD | 400,000 | $1.54 | $616.0K | Form 4 |
| Bucher James B | officer | Sep 18, 2025 | OTHER | 0 | — | — | Form 4 |
| Walker Luke Nathaniel | director | Jun 17, 2025 | AWARD | 57,603 | — | — | Form 4 |
| Skvarka Jan | director | Jun 17, 2025 | AWARD | 57,603 | — | — | Form 4 |
| Johnson David Michael | director | Jun 17, 2025 | AWARD | 57,603 | — | — | Form 4 |
| Kariuki Enoch | director | Jun 17, 2025 | AWARD | 57,603 | — | — | Form 4 |
| Myers Scott Dunseth | director | Jun 17, 2025 | AWARD | 57,603 | — | — | Form 4 |
| Myers Scott Dunseth | director | Apr 30, 2025 | BUY | 21,000 | $1.40 | $29.4K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Feb 6, 2025 | BUY | 20,000 | $2.28 | $45.7K | Form 4 |
| Vultaggio Vincent | PAO and Interim PFO | Feb 3, 2025 | AWARD | 158,586 | — | — | Form 4 |
| Vultaggio Vincent | PAO and Interim PFO | Feb 3, 2025 | SELL | 2,615 | $1.71 | $4.5K | Form 4 |
| Vultaggio Vincent | PAO and Interim PFO | Feb 3, 2025 | AWARD | 35,633 | $1.68 | $59.9K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 3, 2025 | AWARD | 335,907 | — | — | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 3, 2025 | SELL | 14,368 | $1.71 | $24.6K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 3, 2025 | AWARD | 124,714 | $1.68 | $209.5K | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 3, 2025 | AWARD | 934,041 | — | — | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 3, 2025 | SELL | 13,230 | $1.71 | $22.6K | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 3, 2025 | AWARD | 124,714 | $1.68 | $209.5K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Feb 3, 2025 | AWARD | 16,629 | $1.68 | $27.9K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Feb 3, 2025 | AWARD | 16,629 | — | — | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Feb 3, 2025 | AWARD | 59,388 | — | — | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Feb 3, 2025 | AWARD | 59,388 | $1.68 | $99.8K | Form 4 |
| Skvarka Jan | director | Jan 31, 2025 | BUY | 60,000 | $1.72 | $103.4K | Form 4 |
| Walker Luke Nathaniel | director | Jan 31, 2025 | BUY | 14,200 | $1.76 | $25.0K | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Jan 31, 2025 | BUY | 28,500 | $1.73 | $49.3K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Jan 2, 2025 | SELL | 4,411 | $3.12 | $13.8K | Form 4 |
| Bruns Ingmar | Chief Medical Officer | Dec 2, 2024 | AWARD | 712,650 | $3.66 | $2.6M | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Dec 2, 2024 | AWARD | 3,028,800 | $3.66 | $11.1M | Form 4 |
| Myers Scott Dunseth | director | Nov 13, 2024 | AWARD | 260,192 | — | — | Form 4 |
| Bruns Ingmar | officer | Nov 13, 2024 | OTHER | 0 | — | — | Form 4 |
| EASTLAND JULIA MARIE | director, officer: CEO & President | Nov 13, 2024 | OTHER | 0 | — | — | Form 4 |
| Myers Scott Dunseth | director: | Nov 13, 2024 | OTHER | 0 | — | — | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Oct 4, 2024 | SELL | 1,603 | $3.18 | $5.1K | Form 4 |
| Skvarka Jan | director | Jun 21, 2024 | AWARD | 41,581 | — | — | Form 4 |
| Kariuki Enoch | director | Jun 21, 2024 | AWARD | 41,581 | — | — | Form 4 |
| Johnson David Michael | director | Jun 21, 2024 | AWARD | 48,429 | — | — | Form 4 |
| Gallagher Cam | director, officer: President, Interim CFO | May 31, 2024 | SELL | 9,597 | $11.98 | $115.0K | Form 4 |
| Walker Luke Nathaniel | director | May 24, 2024 | AWARD | 72,481 | — | — | Form 4 |
| Walker Luke Nathaniel | director: | May 24, 2024 | OTHER | 0 | — | — | Form 4 |
| HAUSMAN DIANA | Chief Medical Officer | May 9, 2024 | SELL | 3,356 | $12.62 | $42.4K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 12,500 | $18.00 | $225.0K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 10,000 | $42.04 | $420.4K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 2,750 | $47.66 | $131.1K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 25,000 | $11.69 | $292.3K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 17,500 | $23.65 | $413.9K | Form 4 |
| Vultaggio Vincent | Principal Accounting Officer | Apr 5, 2024 | DISPOSED | 6,875 | $52.61 | $361.7K | Form 4 |
| Epperly Melissa B, | Chief Financial Officer | Feb 12, 2024 | SELL | 2,573 | $11.44 | $29.4K | Form 4 |
| Gallagher Cam | director, officer: President | Feb 12, 2024 | SELL | 1,173 | $11.44 | $13.4K | Form 4 |
| HAUSMAN DIANA | Chief Medical Officer | Feb 1, 2024 | AWARD | 337,500 | — | — | Form 4 |
| HAUSMAN DIANA | Chief Medical Officer | Feb 1, 2024 | AWARD | 337,500 | $11.69 | $3.9M | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 1, 2024 | AWARD | 141,000 | — | — | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 2, 2024 | SELL | 1,585 | $11.54 | $18.3K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Feb 1, 2024 | AWARD | 141,000 | $11.69 | $1.6M | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 1, 2024 | AWARD | 112,500 | — | — | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 2, 2024 | SELL | 3,310 | $11.54 | $38.2K | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 1, 2024 | AWARD | 112,500 | $11.69 | $1.3M | Form 4 |
| Paul Andrea | Chief Legal Officer | Feb 1, 2024 | AWARD | 90,000 | $11.69 | $1.1M | Form 4 |
| Gallagher Cam | director, officer: President | Feb 1, 2024 | AWARD | 192,500 | — | — | Form 4 |
| Gallagher Cam | director, officer: President | Feb 2, 2024 | SELL | 11,552 | $11.54 | $133.3K | Form 4 |
| Gallagher Cam | director, officer: President | Feb 1, 2024 | AWARD | 192,500 | $11.69 | $2.3M | Form 4 |
| Epperly Melissa B, | Chief Financial Officer | Feb 1, 2024 | AWARD | 75,000 | — | — | Form 4 |
| Epperly Melissa B, | Chief Financial Officer | Feb 2, 2024 | SELL | 8,669 | $11.54 | $100.0K | Form 4 |
| Epperly Melissa B, | Chief Financial Officer | Feb 1, 2024 | AWARD | 75,000 | $11.69 | $876.8K | Form 4 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | Feb 1, 2024 | AWARD | 250,000 | — | — | Form 4 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | Feb 1, 2024 | TAX W/H | 20,655 | $11.69 | $241.5K | Form 4 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | Feb 1, 2024 | AWARD | 250,000 | $11.69 | $2.9M | Form 4 |
| Lackner Mark | Chief Scientific Officer | Jan 2, 2024 | AWARD | 60,000 | $15.99 | $959.4K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Jan 2, 2024 | AWARD | 40,000 | — | — | Form 4 |
| Lackner Mark | Chief Scientific Officer | Dec 31, 2023 | DISPOSED | 0 | — | — | Form 4 |
| Lackner Mark | Chief Scientific Officer | Dec 31, 2023 | DISPOSED | 23,687 | $23.65 | $560.2K | Form 4 |
| Lackner Mark | Chief Scientific Officer | Dec 31, 2023 | DISPOSED | 215,000 | $25.60 | $5.5M | Form 4 |
| Bunker Kevin D. | Chief Scientific Officer | Dec 20, 2023 | GIFT | 24,158 | — | — | Form 4 |
| Johnson David Michael | director | Nov 10, 2023 | BUY | 17,000 | $9.88 | $167.9K | Form 4 |
| Blackwell Kimberly | director, officer: Chief Executive Officer | Nov 13, 2023 | BUY | 5,000 | $10.29 | $51.4K | Form 4 |